Cervicovaginal HIV-1 Shedding in Pregnant Women near Delivery

Mock P.A. , Shaffer N. , Bhadrakom C. , Siriwasin W. , Chotpitayasunondh T. , Chearskul S. , Young N.L. , Roongpisuthipong A. , Chinayon P. , Kalish M.L. , Parakh B. , Maustro T.D. , & the Bangkok Collaborative Perinatal HIV Transmission Study Group. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. AIDS 1999; 13: 407–414.

Garcia P.M. , Kalish L.A. , Pitt J. , Minkoff H. , Quinn T.C. , Burchett S.K. , Kornegay J. , Jackson B. , Moye J. , Hanson C. , Zorrilla C. , & Lew J F. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. New England Journal of Medicine 1999; 341: 394–402.

Panther L.A. , Tucker L. , Xu C. , Tuomala R.E. , Mullins J.I. , & Anderson D.J. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. Journal of Infectious Diseases 2000; 181: 555–563.

Sperling R.S. , Shapiro D.E. , Coombs R.W. , Todd J.A. , Herman S.A. , McSherry G.D. , O'Sullivan M.J. , Van Dyke R.B. , Jimenez E. , Rouzioux C. , Flynn P.M. , & Sullivan J.L. for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. New England Journal of Medicine 1996, 335: 1621–1629.

Scott G.B. , & Tuomala R. Combination antiretroviral therapy during pregnancy. AIDS 1998; 12: 2495–2497.

Kass N.E. , Taylor H.A. , & Anderson J. Treatment of human immunodeficiency virus during pregnancy: the shift from an exclusive focus on fetal protection to a more balanced approach. American Journal of Obstetrics and Gynecology 2000; 182: 856–859.

Lorenzi P. , Masserey Spicher V. , Lauberau B. , Hirschel B. , Kind C. , Rudin C. , Irion O. , Kaiser L. and the Swiss Cohort Study, the Swiss Collaborative HIV and pregnancy Study and the Swiss Neonatal HIV Study. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998; 12: F241–F247.

McGowan J.P. , Crane M. , Wiznia A.A. , & Blum S. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women. Obstetrics & Gynecology 1999; 94: 641–646.

Clarke S.M. , Mulcahy F. , Healy C.M. , Condon S. , & Butler K.M. The efficacy and tolerability of combination anti-retroviral therapy in pregnancy: infant and maternal outcome. International Journal of STD and AIDS 2000; 11: 220–223.

The European mode of delivery collaboration. Elective caesarean section versus vaginal delivery in preventing vertical HIV-1 transmission: a randomized clinical trial. The Lancet 1999; 353: 1035–1039.

John G.C. , Nduati R.W. , Mbori-Ngacha D.A. , Richardson B.A. , Panteleff D. , Mwatha A. , Overbaugh J. , Bwayo J. , Ndinya-Achola J.O. , & Kreiss J.K. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. Journal of Infectious Diseases 2001; 183: 206–212.

Chuachoowong R. , Shaffer N. , Siriwasin W. , Chaisilwattana P. , Young N.L. , Mock P.A. , Chearskul S. , Waranawat N. , Chaowanachan T. , Karon J. , Simonds R.J. , & Mastro T.D. , for the Bangkok Collaborative Perinatal HIV Transmission Study Group. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Journal of Infectious Diseases 2000; 181: 99–106.

Fiore J.R. , Lepera A. , Di Stefano M.A. , Saracino A. , Favia A. , Pastore G. , & Angarano G. Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women. AIDS 1999; 13: 626–627.